DekaBank Deutsche Girozentrale
PASG icon

DekaBank Deutsche Girozentrale’s Passage Bio PASG Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-715
Closed -$140K – 1464
2021
Q3 		$140K Hold
715
– – ﹤0.01% 1257
2021
Q2 		$188K Hold
715
– – ﹤0.01% 1229
2021
Q1 		$240K Hold
715
– – ﹤0.01% 1154
2020
Q4 		$380K Buy
+715
New +$286K ﹤0.01% 1079

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PASG Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Passage Bio (PASG) in Q4 2021, closing a stake of 715 shares — an estimated $140K sold.

DekaBank Deutsche Girozentrale first reported a position in PASG in Q4 2020 and held it in 4 quarters. The position peaked at $380K in Q4 2020. 99 funds tracked by Wall St. Rank hold PASG as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Passage Bio position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 715 Passage Bio shares in Q4 2021, an estimated $140K.
  • DekaBank Deutsche Girozentrale first reported a position in Passage Bio in Q4 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Passage Bio position peaked at $380K in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Passage Bio as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.